Litcius/Paper detail

New modified thieno[2,3-d]pyrimidine derivatives as VEGFR-2 inhibitors: Design, synthesis, in vitro anti-cancer evaluation and divers in silico studies

Souad A. El‐Metwally, Mariam Omara, Hazem Elkady, Eslam B. Elkaeed, Hanan Al-Ghulikah, Mohammed S. Taghour, Hesham A. El‐Mahdy, Ibrahim M. Ibrahim, Dalal Z. Husein, Ahmed M. Metwaly, Ibrahim H. Eissa

2024Journal of Molecular Structure10 citationsDOI

Topics & Concepts

ChemistryPyrimidineApoptosisIn vitroDocking (animal)Cell cycleCell cycle checkpointKinaseAngiogenesisCancer cellStereochemistryIC50Cancer researchPharmacologyBiochemistryCancerInternal medicineBiologyNursingMedicineSynthesis and biological activityBioactive Compounds and Antitumor AgentsSynthesis and Reactions of Organic Compounds
New modified thieno[2,3-d]pyrimidine derivatives as VEGFR-2 inhibitors: Design, synthesis, in vitro anti-cancer evaluation and divers in silico studies | Litcius